99,377 Shares in Certara, Inc. $CERT Acquired by Trexquant Investment LP

Key Points

• Trexquant Investment LP has acquired a new position in Certara, Inc., purchasing 99,377 shares valued at approximately $984,000, representing about 0.06% of the company's stock.
• Certara's recent quarterly earnings revealed an EPS of $0.07, below the consensus estimate of $0.10, despite a revenue increase of 12.1% year-over-year, totaling $104.57 million.
• Analysts have set a consensus rating of "Moderate Buy" for Certara, with an average price target of $15.14, following recent adjustments from several investment firms.

Trexquant Investment LP bought a new stake in Certara, Inc. (NASDAQ:CERT - Free Report) in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 99,377 shares of the company's stock, valued at approximately $984,000. Trexquant Investment LP owned approximately 0.06% of Certara as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Versant Capital Management Inc grew its position in Certara by 218.8% in the 1st quarter. Versant Capital Management Inc now owns 2,719 shares of the company's stock valued at $27,000 after buying an additional 1,866 shares in the last quarter. Caitong International Asset Management Co. Ltd bought a new position in shares of Certara during the 1st quarter valued at about $31,000. Wells Fargo & Company MN boosted its position in shares of Certara by 48.4% during the 4th quarter. Wells Fargo & Company MN now owns 3,208 shares of the company's stock valued at $34,000 after purchasing an additional 1,047 shares in the last quarter. AlphaQuest LLC bought a new position in shares of Certara during the 1st quarter valued at about $39,000. Finally, Associated Banc Corp bought a new position in shares of Certara in the first quarter valued at $101,000. Institutional investors own 73.96% of the company's stock.

Certara Trading Up 3.3%

CERT stock traded up $0.36 during mid-day trading on Friday, reaching $11.28. 2,057,903 shares of the stock traded hands, compared to its average volume of 1,264,191. The company has a current ratio of 2.16, a quick ratio of 2.16 and a debt-to-equity ratio of 0.27. Certara, Inc. has a 52-week low of $8.64 and a 52-week high of $15.69. The company has a market cap of $1.81 billion, a P/E ratio of 225.65 and a beta of 1.43. The stock's fifty day moving average is $10.73 and its 200-day moving average is $11.28.

Certara (NASDAQ:CERT - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.10 by ($0.03). The company had revenue of $104.57 million during the quarter, compared to analysts' expectations of $104.14 million. Certara had a return on equity of 5.11% and a net margin of 1.97%.Certara's revenue for the quarter was up 12.1% compared to the same quarter last year. During the same period last year, the company earned $0.07 earnings per share. As a group, sell-side analysts expect that Certara, Inc. will post 0.28 earnings per share for the current year.

Analyst Ratings Changes

Several research analysts have issued reports on the company. Morgan Stanley assumed coverage on Certara in a report on Thursday, July 3rd. They issued an "equal weight" rating and a $16.00 price target on the stock. Zacks Research raised Certara from a "strong sell" rating to a "hold" rating in a report on Friday, September 5th. KeyCorp reduced their price objective on shares of Certara from $18.00 to $15.00 and set an "overweight" rating for the company in a research note on Monday, July 14th. Finally, UBS Group reduced their price objective on shares of Certara from $17.50 to $15.00 and set a "buy" rating for the company in a research note on Thursday, August 7th. Five investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $15.14.

Insider Activity

In other news, insider Leif E. Pedersen sold 51,224 shares of the stock in a transaction that occurred on Tuesday, September 9th. The shares were sold at an average price of $10.92, for a total value of $559,366.08. Following the completion of the sale, the insider directly owned 73,979 shares of the company's stock, valued at $807,850.68. This represents a 40.91% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 2.33% of the stock is owned by company insiders.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.